{
    "Trade/Device Name(s)": [
        "Immunalysis Benzodiazepines Urine Enzyme Immunoassay",
        "Immunalysis Multi-Drug Calibrators"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K151771",
    "Predicate Device Reference 510(k) Number(s)": [
        "K930529",
        "K051088"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JXM",
        "DKB"
    ],
    "Summary Letter Date": "December 24, 2015",
    "Summary Letter Received Date": "December 28, 2015",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3170",
        "21 CFR 862.3200"
    ],
    "Regulation Name(s)": [
        "Benzodiazepine test system",
        "Clinical Toxicology Calibrator"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzodiazepines",
        "Oxazepam",
        "Benzoylecgonine",
        "Morphine",
        "PCP"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Beckman Coulter AU 400e"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Benzodiazepines Urine Enzyme Immunoassay and Multi-Drug Calibrators for qualitative and semi-quantitative detection of benzodiazepines and calibration of drug assays in urine using automated chemistry analyzers.",
    "Indications for Use Summary": "Qualitative and semi-quantitative analysis of benzodiazepines in human urine, prescription use only; calibrators for in vitro diagnostic use with immunoassays for benzoylecgonine, morphine, PCP, and oxazepam.",
    "fda_folder": "Toxicology"
}